We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novo Nordisk Recalls Insulin Pens Due to Filling Foul-Ups
Novo Nordisk Recalls Insulin Pens Due to Filling Foul-Ups
November 4, 2013
Danish drugmaker Novo Nordisk is recalling 33 batches of an insulin product in more than a dozen EU countries after a quality review uncovered filling foul-ups that could impact treatment.